Efficacy and safety study of preoperative marking for undetectable hepatic tumor

Phase 1

• Conditions: hepatic tumor requiring surgical resection

• Registration Number: JPRN-UMIN000028608
• Lead Sponsor: Hiroshima University Hospital Department of gastroenterological surgery

Brief Summary

Preoperative marking for liver tumors could be performed without major adverse events.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-08-09
• Study Completion: 2021-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 19

Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with severe (NYHA class III or more) ischemic heart disease. 2. Patient who complicated of severe liver cirrhosis (hepatopathy degree C). 3. Patients with dyspnea requiring oxygen administration due to interstitial pneumonia, pulmonary fibrosis and others. 4. Patients who are undergoing dialysis with chronic renal failure. 5. Patients currently suffering from duplicated cancer of active activity. 6. Patients who are judged to be difficult to participate in research due to psychosis or psychiatric symptoms. 7. Other patients who are deemed inappropriate for the research researcher or research sharing doctor to conduct this research.

Study & Design

• Study Type: Interventional
• Study Design: Not specified